ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,030Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 1904

$932K Total Retail Price of All Prescriptions

Rank: 107 out of 1904

603 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 603 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 585 550 79 1 7
LEVOTHYROXINE SODIUM 546 524 90 2 1
LISINOPRIL 466 430 88 3 3
NAMENDA 455 455 40 4 28
AMLODIPINE BESYLATE 428 401 87 5 6
OMEPRAZOLE 413 383 74 6 5
SIMVASTATIN 381 354 72 7 4
DONEPEZIL HCL 357 357 50 8 32
WARFARIN SODIUM 339 334* 45 9 14
TRAMADOL HCL 334 319 68 10 18
CARVEDILOL 276 250 44 11 24
ATORVASTATIN CALCIUM 265 234 59 12 8
ESCITALOPRAM OXALATE 260 255* 36 13 39
PRAVASTATIN SODIUM 244 213 51 14 10
POTASSIUM CHLORIDE 236 224 38 15 17
METFORMIN HCL 228 179 43 16 9
LOSARTAN POTASSIUM 219 200 45 17 21
ATENOLOL 204 204 38 18 19
CITALOPRAM HBR 201 184 34 19 22
METOPROLOL SUCCINATE 193 193 28 20 16
HYDROCHLOROTHIAZIDE 190 185* 44 21 11
CYMBALTA 188 152 17 22 34
HYDROCODONE-ACETAMINOPHEN 183 159 48 S3 23 2
METOPROLOL TARTRATE 176 171* 31 24 12
CEPHALEXIN 174 169* 84 25 58
MIRTAZAPINE 174 174 38 25 57
GABAPENTIN 172 152 32 27 13
PANTOPRAZOLE SODIUM 170 156 49 28 27
SPIRONOLACTONE 170 165* 28 28 60
CLOPIDOGREL 170 151 28 28 20
POLYETHYLENE GLYCOL 3350 162 157* 49 31 50
FAMOTIDINE* 151 146* 24 32 67
ALLOPURINOL 148 148 25 33 31
KLOR-CON M20 140 135* 28 34 59
LANTUS 134 115 19 35 55
LORAZEPAM 126 106 36 B 36 36
MELOXICAM 115 85 29 37 29
AZITHROMYCIN 112 107* 84 38 46
GLYBURIDE 107 71 19 R 39 141
TAMSULOSIN HCL 106 101* 20 40 26
ADVAIR DISKUS 105 92 24 41 56
SERTRALINE HCL 96 91* 21 42 25
LEVOFLOXACIN 93 88* 58 43 71
VALSARTAN-HYDROCHLOROTHIAZIDE 79 74* 18 44 89
CLONIDINE HCL 79 74* 13 44 66
ALPRAZOLAM 78 73* 24 B 46 15
AMIODARONE HCL 77 77 13 47 194
LOVASTATIN 76 71* 14 48 54
CARBIDOPA-LEVODOPA 76 <11 <11 48 113
HUMALOG 74 <11 <11 50 111
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 67* 34 51 84
DIGOX 71 71 11 52 126
LEVETIRACETAM 70 <11 <11 53 101
TRAZODONE HCL 69 64* 16 54 47
ALENDRONATE SODIUM 68 68 12 55 35
FLUTICASONE PROPIONATE 67 62* 21 56 49
PREDNISONE 66 61* 33 57 40
ZOLPIDEM TARTRATE 65 52 14 58 30
CRESTOR 64 <11 <11 59 33
DIOVAN 62 62 11 60 61
PROAIR HFA 62 48 32 60 45
LOSARTAN-HYDROCHLOROTHIAZIDE 62 57* 12 60 48
DETROL LA 61 <11 <11 63 185
NUEDEXTA 60 <11 <11 64 221
VERAPAMIL ER 59 54* 11 65 112
BYSTOLIC 59 <11 <11 65 90
LIDODERM 58 <11 <11 67 171
OXYBUTYNIN CHLORIDE ER 58 <11 <11 67 129
VESICARE 58 <11 <11 67 149
CEFDINIR 55 50* 41 70 167
DILTIAZEM 24HR CD 55 <11 <11 70 159
PROPRANOLOL HCL 55 <11 <11 70 132
EXELON 52 <11 <11 73 123
DIVALPROEX SODIUM 51 <11 <11 74 86
ISOSORBIDE MONONITRATE ER 51 <11 <11 74 64
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.